Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS–ADRDA criteria

These new criteria are centred on a clinical core of early and significant episodic memory impairment and stipulate that there must also be at least one or more abnormal biomarkers among structural MRI, molecular neuroimaging with PET, and cerebrospinal fluid analysis of amyloid beta or tau proteins.